Does IMATINIB Cause Myelofibrosis? 76 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 76 reports of Myelofibrosis have been filed in association with IMATINIB (Imatinib). This represents 0.2% of all adverse event reports for IMATINIB.
76
Reports of Myelofibrosis with IMATINIB
0.2%
of all IMATINIB reports
16
Deaths
9
Hospitalizations
How Dangerous Is Myelofibrosis From IMATINIB?
Of the 76 reports, 16 (21.1%) resulted in death, 9 (11.8%) required hospitalization.
Is Myelofibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IMATINIB. However, 76 reports have been filed with the FAERS database.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Myelofibrosis?
RUXOLITINIB (1,316)
ELTROMBOPAG (89)
ROMIPLOSTIM (89)
HYDROXYUREA (88)
DEFERASIROX (57)
MOMELOTINIB (51)
ASPIRIN (46)
RITUXIMAB (43)
ANAGRELIDE (41)
ELTROMBOPAG OLAMINE (39)
Which IMATINIB Alternatives Have Lower Myelofibrosis Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL